Nature Reviews：胰腺癌研究的3大新发现（年度回顾） | 热心肠日报
The war against pancreatic cancer in 2020 — advances on all fronts
2020年对抗胰腺癌的战争——各方面的进展
10.1038/s41575-020-00410-4
01-07, Review
Abstract & Authors:展开
Abstract:收起
In 2020, important advances were made across three major frontiers of pancreatic ductal adenocarcinoma (PDAC) research: risk factors, therapeutic resistance and tumour recurrence. Pathophysiology of obesity-mediated PDAC initiation was elucidated, novel stromal mechanisms of therapeutic resistance were unveiled and the genetic evolution of recurrent PDAC under therapeutic pressures was tracked in human samples.
First Authors:
Tejeshwar Jain
Correspondence Authors:
Vikas Dudeja
All Authors:
Tejeshwar Jain,Vikas Dudeja
赞 (0)